We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Correction to "Naltrexone‐bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports.".
- Authors
Onakpoya, Igho J.
- Abstract
A correction has been made to a systematic review and meta-analysis of unpublished clinical study reports on the use of naltrexone-bupropion (Mysimba) in managing obesity. The correction involves replacing the term "serious adverse events" with "severe adverse events" throughout the manuscript, as well as making corresponding corrections to Table 3 and Figure 4. The corrected data on serious adverse events has been included in the text and a new figure (Figure 5) has been added. The correction does not affect the analyses and conclusions of the study. The authors express gratitude to Dr. Cait O'Sullivan for bringing the error to their attention.
- Subjects
OBESITY
- Publication
British Journal of Clinical Pharmacology, 2024, Vol 90, Issue 6, p1531
- ISSN
0306-5251
- Publication type
Article
- DOI
10.1111/bcp.16065